Freenome vs Khartis Therapeutics, Inc.
Freenome vs Khartis Therapeutics, Inc., compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Freenome is on 59/100 and Khartis Therapeutics, Inc. on 53/100.
Where each one leads
Freenome
- our overall score: 59/100 against 53/100
- funding raised: $570M against $50.0M
Khartis Therapeutics, Inc.
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Freenome | Khartis Therapeutics, Inc. |
|---|---|---|
| What it is | Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology. | Developing oral small molecule medicines for immunological and chronic diseases. |
| Category | Biotechnology, Healthcare, Artificial Intelligence, Biotech | Biotechnology, Pharmaceuticals, Drug Discovery, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2014 | 2021 |
| Headquarters | South San Francisco, USA | San Diego, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Freenome | Khartis Therapeutics, Inc. |
|---|---|---|
| Employees | 402 | Not published |
| Total funding | $570M | $50.0M |
| Latest round | Series D | Series B |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 46,860 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Freenome | Khartis Therapeutics, Inc. |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 53/100 |
| Traction | 60/100 | 38/100 |
| Team | Not published | 50/100 |
| Search visibility | 31/100 | Not published |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (46/100) | D (50/100) |
| Domain ratingLink authority, 0-100 | 56/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Freenome | Khartis Therapeutics, Inc. |
|---|---|---|
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Tag Manager | Not detected |
| Support stack | HubSpot | Not detected |
Freenome vs Khartis Therapeutics, Inc.: common questions
Which is better, Freenome or Khartis Therapeutics, Inc.?
On our 0-100 score Freenome rates higher (59/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Freenome and Khartis Therapeutics, Inc. compare on the numbers?
Freenome leads on our overall score (59/100 against 53/100), funding raised ($570M against $50.0M).
Read the full Freenome review and pricing or the Khartis Therapeutics, Inc. review and pricing. You can also browse other Freenome alternatives we track.